Hydroxyurea for Sickle Cell Disease
How It Works
Hydroxyurea increases Reference fetal hemoglobin Opens New Window (HbF) production and slightly raises the total Reference hemoglobin Opens New Window concentration in the body. Fetal hemoglobin reduces the chance that red blood cells will sickle in a person who has Reference sickle cell disease Opens New Window. So increased production of HbF can reduce the occurrence of sickling-related complications.
|By:||Reference Healthwise Staff||Last Revised: October 1, 2012|
|Medical Review:||Reference E. Gregory Thompson, MD - Internal Medicine
Reference Martin Steinberg, MD - Hematology